What are the segments under the Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market?

The market is segmented by product type (molecular diagnostics, immunoassays, biosensors, others) and by application (hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, research and academic institutes, homecare settings).

Which is the most dominant region for the Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market?

North America is the most dominant region due to advanced healthcare infrastructure, high adoption rates of new technologies, and significant market players in the region.

Who are the leading players in the Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market?

Key players include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Siemens Healthineers, Quidel Corporation, bioMérieux SA, Danaher Corporation, Bio-Rad Laboratories, and Meridian Bioscience.

Point of Care Testing for Vancomycin-Resistant Enterococcus Market | Size, Share, Growth

Q: What is the size of the Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market?

The Global Point of Care Testing for Vancomycin-Resistant Enterococcus (VRE) Market was valued at approximately USD 0.8 billion in 2023 and is projected to grow at a CAGR of 9.5% from 2024 to 2030. By 2030, the market is expected to reach around USD 1.51 billion.

Q: What are the Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market drivers?

Major drivers include the rising incidence of hospital-acquired infections (HAIs), advancements in testing technologies, and increased awareness and government initiatives on antimicrobial resistance (AMR).